Clinical Trial

Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Phase 2 trial to evaluate safety and immunogenicity of Inventprise's (IVT) 25-valent pneumococcal conjugate vaccine (IVT PCV-25) in Healthy Infants
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-01-21; most recent amendment 2025-08-29.
Status change: Recruiting → Active, Not Recruiting 2025-04-14
Status change: Not Yet Recruiting → Recruiting 2025-01-27
Trial Details
NCT Number NCT06790290
Lead Sponsor Inventprise Inc.
Collaborators: University of the Philippines-National Health Institute_Doña Nena Health Center, Health Index Multispecialty Clinic, Grand Centennial Homes Clinic
Conditions Pneumococcal Disease, Invasive
Enrollment 421 participants
Start Date 2025-01-27
Primary Completion 2025-04-03 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-09-02